comparemela.com

Page 6 - Meyer Handelman Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Exxon Mobil Co (NYSE:XOM) Shares Sold by Kiley Juergens Wealth Management LLC

Exxon Mobil Co (NYSE:XOM) Shares Sold by Kiley Juergens Wealth Management LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Toth Financial Advisory Corp Sells 380 Shares of Exxon Mobil Co (NYSE:XOM)

Toth Financial Advisory Corp lessened its stake in Exxon Mobil Co. (NYSE:XOM – Free Report) by 5.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,031 shares of the oil and gas company’s stock after selling 380 shares during the quarter. Toth Financial Advisory […]

Inlet Private Wealth LLC Has $2 06 Million Stake in Exxon Mobil Co (NYSE:XOM)

Inlet Private Wealth LLC boosted its holdings in shares of Exxon Mobil Co. (NYSE:XOM – Free Report) by 0.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,584 shares of the oil and gas company’s stock after buying an additional […]

Harbour Trust & Investment Management Co Takes Position in Exxon Mobil Co (NYSE:XOM)

Harbour Trust & Investment Management Co bought a new position in Exxon Mobil Co. (NYSE:XOM – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 106,701 shares of the oil and gas company’s stock, valued at approximately $10,668,000. Exxon Mobil accounts […]

Turtle Creek Wealth Advisors LLC Invests $91,000 in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Turtle Creek Wealth Advisors LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 104 shares of the biopharmaceutical company’s stock, valued at approximately $91,000. A number of other institutional investors have also recently added to or reduced their stakes […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.